Stocks keep on gaining - Wednesday Review, November 11

By: Miguel A. Rodriguez

11:44, 12 November 2020

The potential COVID-19 vaccine moved the markets for the third consecutive day

The US

The benchmarks traded mixedly, part of them reacting to the fact that new restrictions might be imposed to curb the spread of COVID-19. On the other hand, others were driven by Microsoft and Apple's success following the launch of their new products. USA30 fell 0.08%, while USA500 gained 0.78%. TECH100 added 2.01%.

Crude settled up 1.5% at $41.99 per barrel. Brent rose 1% at $44.05.

Gold settled down 0.8% at $1,861.40 per ounce.

The Dollar Index traded at 92.741.

 

Asia and Australia

The markets closed higher over optimism that a viable COVID-19 vaccine could be successfully developed and launched. HongKong45 gained 2.24%.

Japan225 rose 5.41%.

Down under, Australia200 traded 1.79% higher.

 

Europe

Pfizer's potential COVID-19 still impacted the markets. Also, Europe was looking forward to Christine Lagarde's speech regarding the economic outlook and stimulus prospects. Europe50 climbed 0.4%. Germany30hit a one-month high after adding 0.56%. France40 went up 0.4%, while UK100 closed 0.2% higher.

EUR/USD closed at 1.1827 after it gained 0.1%.

Sources: investing.com, reuters.com

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.